Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NovoRapid in pregnancy - safety and efficacy versus human insulin.

Trial Profile

NovoRapid in pregnancy - safety and efficacy versus human insulin.

Phase of Trial: Phase IV

Latest Information Update: 21 May 2012

At a glance

  • Drugs Insulin aspart (Primary) ; Insulin
  • Indications Pregnancy; Pregnancy complications; Preterm birth; Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 01 Mar 2010 Exploratory analysis comparing patients randomised pre-conception and patient randomised in early pregnancy published in Diabetes Care.
    • 12 May 2009 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
    • 01 Mar 2009 Cost-effectiveness analysis published in Current Medical Research and Opinion.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top